$MRNA stock has now fallen 3% today, according to our price data from Polygon. There has been approximately $163,443,181 of trading volume.
Here is what we see in our data on $MRNA (you can track the company live on Quiver's $MRNA stock page):$MRNA Insider Trading Activity
$MRNA insiders have traded $MRNA stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MRNA stock by insiders over the last 6 months:
- ABBAS HUSSAIN sold 312 shares for an estimated $8,736
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MRNA Hedge Fund Activity
We have seen 317 institutional investors add shares of $MRNA stock to their portfolio, and 428 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TWO SIGMA ADVISERS, LP added 4,007,200 shares (+105.2%) to their portfolio in Q2 2025, for an estimated $110,558,648
- WELLINGTON MANAGEMENT GROUP LLP removed 2,856,750 shares (-98.7%) from their portfolio in Q2 2025, for an estimated $78,817,732
- BAILLIE GIFFORD & CO removed 2,854,434 shares (-11.4%) from their portfolio in Q2 2025, for an estimated $78,753,834
- TWO SIGMA INVESTMENTS, LP added 2,505,105 shares (+56.2%) to their portfolio in Q2 2025, for an estimated $69,115,846
- UBS GROUP AG removed 2,435,305 shares (-38.2%) from their portfolio in Q2 2025, for an estimated $67,190,064
- FEDERATED HERMES, INC. added 2,251,497 shares (+364.5%) to their portfolio in Q2 2025, for an estimated $62,118,802
- ROYAL BANK OF CANADA added 1,921,323 shares (+202.4%) to their portfolio in Q2 2025, for an estimated $53,009,301
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$MRNA Congressional Stock Trading
Members of Congress have traded $MRNA stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $MRNA stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$MRNA Analyst Ratings
Wall Street analysts have issued reports on $MRNA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 3 firms issue sell ratings.
Here are some recent analyst ratings:
- Leerink Partners issued a "Underperform" rating on 08/22/2025
- B of A Securities issued a "Underperform" rating on 07/22/2025
- JP Morgan issued a "Underweight" rating on 05/22/2025
- UBS issued a "Buy" rating on 05/02/2025
To track analyst ratings and price targets for $MRNA, check out Quiver Quantitative's $MRNA forecast page.
$MRNA Price Targets
Multiple analysts have issued price targets for $MRNA recently. We have seen 8 analysts offer price targets for $MRNA in the last 6 months, with a median target of $29.5.
Here are some recent targets:
- Mani Foroohar from Leerink Partners set a target price of $15.0 on 08/22/2025
- Gena Wang from Barclays set a target price of $31.0 on 08/04/2025
- Dimple Gosai from B of A Securities set a target price of $25.0 on 07/22/2025
- Jessica Fye from JP Morgan set a target price of $26.0 on 05/22/2025
- Eliana Merle from UBS set a target price of $70.0 on 05/02/2025
- Luca Issi from RBC Capital set a target price of $28.0 on 05/02/2025
- Cory Kasimov from Evercore ISI Group set a target price of $32.0 on 05/02/2025
You can track data on $MRNA on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
